FDA Releases Guidance: Use of Nucleic Acid Tests to Reduce the Risk of Transmission of Hepatitis B Virus

FDA Draft Guidance: Use of Nucleic Acid Tests to Reduce the Risk of Transmission of Hepatitis B Virus from Donors of Human Cells, Tissues, and Cellular and Tissue-Based Products

Federal Register Announcement, August 17, 2016

FDA Draft Guidance for Industry: Use of Nucleic Acid Tests to Reduce the Risk of Transmission of Hepatitis B Virus from Donors of Human Cells, Tissues, and Cellular and Tissue-Based Products, published January 2016

FDA Guidance for Industry: Eligibility Determination for Donors of Human Cells, Tissues, and Cellular and Tissue-Based Products (HCT/Ps), published August 8, 2007